Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Timothy R Watkins

Showing results (31-40 of 54) with videos related to

Pageof 6
Sort By:
Journal of Clinical Pharmacology|August 30, 2024
Pharmacokinetics and Safety of Cilofexor and Firsocostat in Healthy Japanese and Non-Japanese ParticipantsIslam R Younis, Cara Nelson, Elijah J Weber, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|November 18, 2023
Derivation and validation of a noninvasive prediction tool to identify pulmonary hypertension in patients with IPF: Evolution of the model FORDSteven D Nathan, Abhimanyu Chandel, Ya Wang, et al.
Journal of Clinical Pharmacology|May 2, 2023
Effect of Hepatic Impairment on the Pharmacokinetics and Pharmacodynamics of Cilofexor, a Selective Nonsteroidal Farnesoid X Receptor AgonistIslam R Younis, Chia-Hsiang Hsueh, Cara Nelson, et al.
Journal of Critical Care|August 14, 2013
Red blood cell transfusion is associated with decreased in-hospital muscle strength among critically ill patients requiring mechanical ventilationElizabeth C Parsons, Erin K Kross, Naeem A Ali, et al.
The Journal of Infectious Diseases|September 30, 2017
Supplemental Oxygen-Free Days in Hematopoietic Cell Transplant Recipients With Respiratory Syncytial VirusAlpana Waghmare, Hu Xie, Louise Kimball, et al.
Bone Marrow Transplantation|April 20, 2018
Alveolar levels of immuno-inflammatory mediators in diffuse alveolar hemorrhage after allogeneic transplantLisa K Vande Vusse, Mark M Wurfel, David M Madtes, et al.
Diabetes, Obesity & Metabolism|May 15, 2025
Antidiabetic and lipid-lowering medication use inversely linked with serum biomarkers of liver fibrosisJun Wang, Dora Ding, Xiaorong Shao, et al.
The European Respiratory Journal|July 3, 2025
Development and validation of a predictive 6-minute walk score in patients with Idiopathic Pulmonary FibrosisSteven D Nathan, Jie Gao, Ho Cheol Kim, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|July 16, 2023
ALPINE2: Efficacy and safety of 14-day vs 28-day inhaled aztreonam for Pa eradication in children with cystic fibrosisFrancis J Gilchrist, Stephanie Bui, Silvia Gartner, et al.
Gastroenterology|November 10, 2025
The ANTICIPATE-NASH Models Stratify Better the Risk of Clinical Events Than Histology in Metabolic Dysfunction-Associated Steatotic Liver Disease Patients With Advanced Chronic Liver DiseaseLaia Aceituno, Juan Bañares, Mònica Pons, et al.
Pageof 6

Showing results (31-40 of 54) with videos related to

Sort By:
Pageof 6
Journal of Clinical Pharmacology|August 30, 2024
Pharmacokinetics and Safety of Cilofexor and Firsocostat in Healthy Japanese and Non-Japanese ParticipantsIslam R Younis, Cara Nelson, Elijah J Weber, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|November 18, 2023
Derivation and validation of a noninvasive prediction tool to identify pulmonary hypertension in patients with IPF: Evolution of the model FORDSteven D Nathan, Abhimanyu Chandel, Ya Wang, et al.
Journal of Clinical Pharmacology|May 2, 2023
Effect of Hepatic Impairment on the Pharmacokinetics and Pharmacodynamics of Cilofexor, a Selective Nonsteroidal Farnesoid X Receptor AgonistIslam R Younis, Chia-Hsiang Hsueh, Cara Nelson, et al.
Journal of Critical Care|August 14, 2013
Red blood cell transfusion is associated with decreased in-hospital muscle strength among critically ill patients requiring mechanical ventilationElizabeth C Parsons, Erin K Kross, Naeem A Ali, et al.
The Journal of Infectious Diseases|September 30, 2017
Supplemental Oxygen-Free Days in Hematopoietic Cell Transplant Recipients With Respiratory Syncytial VirusAlpana Waghmare, Hu Xie, Louise Kimball, et al.
Bone Marrow Transplantation|April 20, 2018
Alveolar levels of immuno-inflammatory mediators in diffuse alveolar hemorrhage after allogeneic transplantLisa K Vande Vusse, Mark M Wurfel, David M Madtes, et al.
Diabetes, Obesity & Metabolism|May 15, 2025
Antidiabetic and lipid-lowering medication use inversely linked with serum biomarkers of liver fibrosisJun Wang, Dora Ding, Xiaorong Shao, et al.
The European Respiratory Journal|July 3, 2025
Development and validation of a predictive 6-minute walk score in patients with Idiopathic Pulmonary FibrosisSteven D Nathan, Jie Gao, Ho Cheol Kim, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|July 16, 2023
ALPINE2: Efficacy and safety of 14-day vs 28-day inhaled aztreonam for Pa eradication in children with cystic fibrosisFrancis J Gilchrist, Stephanie Bui, Silvia Gartner, et al.
Gastroenterology|November 10, 2025
The ANTICIPATE-NASH Models Stratify Better the Risk of Clinical Events Than Histology in Metabolic Dysfunction-Associated Steatotic Liver Disease Patients With Advanced Chronic Liver DiseaseLaia Aceituno, Juan Bañares, Mònica Pons, et al.
Pageof 6